Bivalirudin
|
Thrombin inhibitors
|
16-Aug-2023 |
Bismuth subsalicylate, metronidazole, and tetracycline
|
H. pylori eradication agents
|
16-Aug-2023 |
Bisacodyl (oral and rectal)
|
Laxatives
|
16-Aug-2023 |
Bisacodyl and polyethylene glycol (peg) 3350 with electrolytes
|
Laxatives
|
16-Aug-2023 |
Biotene dry mouth
|
Mouth and throat products
|
16-Aug-2023 |
Biopatch
|
Antiseptic and germicides
|
16-Aug-2023 |
Biofreeze
|
Topical rubefacient
|
16-Aug-2023 |
Bioflavonoids
|
Vitamins
|
16-Aug-2023 |
Binimetinib
|
Multikinase inhibitors
|
16-Aug-2023 |
Bimatoprost topical ophthalmic
|
Miscellaneous topical agents
|
16-Aug-2023 |
Bimatoprost ophthalmic implant
|
Ophthalmic glaucoma agents
|
16-Aug-2023 |
Bimatoprost ophthalmic
|
Ophthalmic glaucoma agents
|
16-Aug-2023 |
Bifidobacterium, lactobacillus, and streptococcus
|
Probiotics
|
16-Aug-2023 |
Bifidobacterium and lactobacillus
|
Probiotics
|
16-Aug-2023 |
Bicarsim forte
|
Drugs
|
16-Aug-2023 |
Bezlotoxumab
|
Immune globulins
|
16-Aug-2023 |
Bexarotene (topical)
|
Miscellaneous topical agents
|
16-Aug-2023 |
Bexarotene (systemic) (monograph)
|
Drugs
|
16-Aug-2023 |
Bexarotene
|
Miscellaneous antineoplastics
|
16-Aug-2023 |
Bexagliflozin
|
SGLT-2 inhibitors
|
16-Aug-2023 |
Bevacizumab
|
VEGF/VEGFR inhibitors
|
16-Aug-2023 |
Betony
|
Drugs
|
16-Aug-2023 |
Betibeglogene autotemcel
|
Miscellaneous uncategorized agents
|
16-Aug-2023 |
Bethanechol
|
Miscellaneous genitourinary tract agents
|
16-Aug-2023 |
Betaxolol ophthalmic
|
Ophthalmic glaucoma agents
|
16-Aug-2023 |
Betaxolol (systemic) (monograph)
|
Drugs
|
16-Aug-2023 |
Betaxolol (eent) (monograph)
|
Drugs
|
16-Aug-2023 |
Betaxolol
|
Cardioselective beta blockers
|
16-Aug-2023 |
Bazedoxifene and conjugated estrogens
|
Sex hormone combinations
|
16-Aug-2023 |
Bazedoxifene (monograph)
|
Drugs
|
16-Aug-2023 |
Bayer select decongestant
|
Upper respiratory combinations
|
16-Aug-2023 |
Bayberry
|
Drugs
|
16-Aug-2023 |
Basiliximab
|
Interleukin inhibitors
|
16-Aug-2023 |
Barley grass
|
Drugs
|
16-Aug-2023 |
Barium sulfate (oral/rectal)
|
Non-iodinated contrast media
|
16-Aug-2023 |
Baricitinib
|
Antirheumatics
|
16-Aug-2023 |
Barberry
|
Herbal products
|
16-Aug-2023 |
Banaba
|
Drugs
|
16-Aug-2023 |
Bamlanivimab
|
Miscellaneous antivirals
|
16-Aug-2023 |
Balsam peru and castor oil topical
|
Miscellaneous topical agents
|
16-Aug-2023 |
Baloxavir marboxil
|
Miscellaneous antivirals
|
16-Aug-2023 |
Avonex prefilled syringe
|
Interferons
|
16-Aug-2023 |
Avonex pen
|
Interferons
|
16-Aug-2023 |
Aubra eq
|
Contraceptives
|
16-Aug-2023 |
Aubra
|
Contraceptives
|
16-Aug-2023 |
Atropine-1
|
Mydriatics
|
16-Aug-2023 |
Astepro allergy
|
Nasal antihistamines and decongestants
|
16-Aug-2023 |
Aspercreme warming pain relief patch
|
Miscellaneous topical agents
|
16-Aug-2023 |
Aspercreme arthritis pain
|
Topical non-steroidal anti-inflammatories
|
16-Aug-2023 |
Antivenom (centruroides scorpion)
|
Antitoxins and antivenins
|
16-Aug-2023 |
Antivenin (latrodectus mactans) (equine) (monograph)
|
Drugs
|
16-Aug-2023 |
Antivenin (crotalidae) polyvalent
|
Antitoxins and antivenins
|
16-Aug-2023 |
Antithymocyte globulin (equine) (monograph)
|
Drugs
|
16-Aug-2023 |
Antithrombin iii (monograph)
|
Drugs
|
16-Aug-2023 |
Amrix
|
Skeletal muscle relaxants
|
16-Aug-2023 |
Ampicillin (injection)
|
Aminopenicillins
|
16-Aug-2023 |
Ampicillin and sulbactam
|
Beta-lactamase inhibitors
|
16-Aug-2023 |
Amphotericin b liposomal
|
Polyenes
|
16-Aug-2023 |
Amphotericin b lipid complex
|
Polyenes
|
16-Aug-2023 |
Amphotericin b
|
Polyenes
|
16-Aug-2023 |
Amphetamine sulfate
|
CNS stimulants
|
16-Aug-2023 |
Amphetamine and dextroamphetamine
|
CNS stimulants
|
16-Aug-2023 |
Amoxicillin, omeprazole, and rifabutin
|
H. pylori eradication agents
|
16-Aug-2023 |
Amoxicillin, clarithromycin, and vonoprazan
|
H. pylori eradication agents
|
16-Aug-2023 |
Amoxicillin, clarithromycin, and omeprazole
|
H. pylori eradication agents
|
16-Aug-2023 |
Amoxicillin, clarithromycin, and lansoprazole
|
H. pylori eradication agents
|
16-Aug-2023 |
Amoxicillin and vonoprazan
|
H. pylori eradication agents
|
16-Aug-2023 |
Amoxicillin and clavulanate potassium
|
Beta-lactamase inhibitors
|
16-Aug-2023 |
Amoxapine
|
Tricyclic antidepressants
|
16-Aug-2023 |
Ammonium lactate topical
|
Topical emollients
|
16-Aug-2023 |
Ammonium lactate and urea (topical)
|
Topical emollients
|
16-Aug-2023 |
Amlodipine, hydrochlorothiazide, and valsartan
|
Miscellaneous antihypertensive combinations
|
16-Aug-2023 |
Amlodipine, hydrochlorothiazide, and olmesartan
|
Miscellaneous antihypertensive combinations
|
16-Aug-2023 |
Amlodipine and valsartan
|
Angiotensin II inhibitors with calcium channel blockers
|
16-Aug-2023 |
Amlodipine and telmisartan
|
Angiotensin II inhibitors with calcium channel blockers
|
16-Aug-2023 |
Amlodipine and perindopril
|
ACE inhibitors with calcium channel blocking agents
|
16-Aug-2023 |
Amlodipine and olmesartan
|
Angiotensin II inhibitors with calcium channel blockers
|
16-Aug-2023 |
Amlodipine and celecoxib
|
Cox-2 inhibitors
|
16-Aug-2023 |
Amlodipine and benazepril
|
ACE inhibitors with calcium channel blocking agents
|
16-Aug-2023 |
Amlodipine and atorvastatin
|
Antihyperlipidemic combinations
|
16-Aug-2023 |